
Simply Speaking® Hepatitis




Simply Speaking® Hepatitis is organized by Practice Point Communications (PPC).
Accreditation:
Physicians/Physician Assistants:
The University of Nebraska Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses/Nurse Practitioners:
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity. Provider approved by the California Board of Registered Nursing, Provider Number 13699 for 1.2 contact hours.
Pharmacists (PharmDs/RPhs):
This knowledge-based activity is accredited for 1 hour of continuing pharmacy education (CPE) credit. Duquesne University School of Pharmacy will report all credit to CPE Monitor within 60 working days after receiving evidence of successful completion of the course. Successful completion means that you must attend the entire program and complete an evaluation form.
Overview:
What is Simply Speaking® Hepatitis?
• An educational series accredited by University of Nebraska Medical Center (UNMC) and Duquesne University School of Pharmacy (DU)
• Live, accredited continuing education activities compliant with evolving ACCME Guidelines
• Regional educational opportunities for MD, DO, PA, NP, RN and PharmD healthcare professionals
• A continuous?,? annually funded initiative with a dedicated Therapeutic Advisor and UNMC Planning Committee ?that meets quarterly to discuss process, logistics and content enhancements and ongoing Joint Accreditation compliance?
• A proven process of identifying, certifying and evaluating national and regional healthcare experts
Why participate in Simply Speaking® Hepatitis?
• Content development and training provided by well-known and credible educators participating within Simply Speaking®
• This series is available free of charge to a variety of institutions (clinics, hospitals, specialty organizations) wanting to improve health care provider education
Topics:
First Steps in HCV Elimination: Improved Screening and Linkage-to-Care Approaches:
Critical to achieving the elimination of HCV infection is identifying HIV-infected persons with improved screening and surveillance approaches and linking them to HCV care and treatment. These steps will reduce the incidence of HCV, cirrhosis, HCC, liver-related deaths, and retransmission of HCV. This activity reviews the changing epidemiology/ demographics of HCV infection and burden of disease and discusses screening and linkage-to-care approaches important to achieving the elimination of HCV infection in the United States.
HCV Elimination in PWIDs and the Incarcerated:
The national strategy for the elimination of HCV in the United States calls for a 90% reduction in the incidence of HCV and having 90% of those with HCV being treated. Scaling up HCV treatment in persons who inject drugs (PWIDs) and persons who are incarcerated is necessary to achieve HCV elimination targets. This activity will address important issues for PWIDs and the incarcerated with HCV, including epidemiologic trends, prevention strategies, and AASLD recommendations for contemporary HCV management approaches/challenges and harm-reduction approaches.